Cargando…

Diagnostic and Prognostic Implications of FGFR3(high)/Ki67(high) Papillary Bladder Cancers

Prognostic/therapeutic stratification of papillary urothelial cancers is solely based upon histology, despite activated FGFR3-signaling was found to be associated with low grade tumors and favorable outcome. However, there are FGFR3-overexpressing tumors showing high proliferation—a paradox of coexi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geelvink, Mirja, Babmorad, Armin, Maurer, Angela, Stöhr, Robert, Grimm, Tobias, Bach, Christian, Knuechel, Ruth, Rose, Michael, Gaisa, Nadine T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163244/ https://www.ncbi.nlm.nih.gov/pubmed/30154342 http://dx.doi.org/10.3390/ijms19092548

Ejemplares similares

Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup
por: Baldia, Philipp H., et al.
Publicado: (2016)

EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
por: Rose, Michael, et al.
Publicado: (2020)

Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
por: Jung, Max, et al.
Publicado: (2023)

Comparative genomic profiling of glandular bladder tumours
por: Maurer, Angela, et al.
Publicado: (2020)

Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
por: Weyerer, Veronika, et al.
Publicado: (2020)

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
por: Tang, Jingdong, et al.
Publicado: (2018)

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma
por: Viana, Aline de Oliveira Ribeiro, et al.
Publicado: (2020)

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy
por: Schnitzler, Tician, et al.
Publicado: (2020)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms
por: Qi, Gaoxiu, et al.
Publicado: (2023)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Ki-67 Expression as a Predictive Factor of Muscle Invasion in Bladder Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2018)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Circulating tumor cells correlating with Ki-67 predicts the prognosis of bladder cancer patients
por: Liu, Jie, et al.
Publicado: (2022)

Invited Commentary: The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Barczyński, Marcin
Publicado: (2021)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Acute Hypersensitivity Pneumonitis Associated With a High Ki-67 Proliferative Index
por: Nabrinsky, Edward, et al.
Publicado: (2020)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Association of smoking, p53 and Ki-67 immunomarkers with bladder neoplasms in tribal region of India
por: Vaishnav, Mitsu, et al.
Publicado: (2022)

Epigenetic inactivation of ST6GAL1 in human bladder cancer
por: Antony, Pia, et al.
Publicado: (2014)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved
por: Luo, Yihuan, et al.
Publicado: (2016)

Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance.
por: Bush, C., et al.
Publicado: (1991)

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
por: Tian, Yuejun, et al.
Publicado: (2016)

Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Malignant adenohypophysis spindle cell oncocytoma with repeating recurrences and a high Ki-67 index
por: Kong, Xiangyi, et al.
Publicado: (2017)

High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma
por: Deng, Han-Yu, et al.
Publicado: (2017)

Clinicopathological characteristics of peripheral clinical stage IA lung adenocarcinoma with high Ki-67 expression
por: Liu, Zhan, et al.
Publicado: (2021)

Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma
por: Zhao, Yu-meng, et al.
Publicado: (2023)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
por: Vetterlein, Malte W., et al.
Publicado: (2017)

Ki-67 biomarker in breast cancer of Indian women
por: Patil, Amit V., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8d7dbqb0im8trj0jsfu5r2u5om